Applied Genetic Techs
(NASDAQ:AGTC)
$0.3936
0.0048[1.23%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$0.37
-0.0236[-6.00%]
After Hours: 9:09AM EDT
Day Range0.37 - 0.452 Wk Range0.23 - 2.83Open / Close0.37 / 0.39Float / Outstanding67.4M / 67.6M
Vol / Avg.757.8K / 1.3MMkt Cap26.6MP/E-50d Avg. Price0.33
Div / Yield-Payout Ratio-Total Float67.4MEPS-0.28

Applied Genetic Techs Stock (NASDAQ:AGTC), Quotes and News Summary

Applied Genetic Techs Stock (NASDAQ: AGTC) stock price, news, charts, stock research, profile.

Loading...
Day Range0.37 - 0.452 Wk Range0.23 - 2.83Open / Close0.37 / 0.39Float / Outstanding67.4M / 67.6M
Vol / Avg.757.8K / 1.3MMkt Cap26.6MP/E-50d Avg. Price0.33
Div / Yield-Payout Ratio-Total Float67.4MEPS-0.28
Globe Newswire - Sep 1, 2022, 8:00AM
Globe Newswire - Aug 1, 2022, 4:05PM
Globe Newswire - Jul 12, 2022, 4:01PM
Globe Newswire - Jun 8, 2022, 8:00AM
InvestorPlace - Jul 24, 2022, 8:41AM
Sector: Health Care.Industry: Biotechnology
Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 and ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology, and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q1 2023Est.ActualSurprise
EPS-0.280-0.280 0.0000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Applied Genetic Techs (AGTC) stock?

A

You can purchase shares of Applied Genetic Techs (NASDAQ: AGTC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Applied Genetic Techs's (AGTC) competitors?

Q

What is the target price for Applied Genetic Techs (AGTC) stock?

A

The latest price target for Applied Genetic Techs (NASDAQ: AGTC) was reported by Wells Fargo on Tuesday, October 25, 2022. The analyst firm set a price target for 0.40 expecting AGTC to rise to within 12 months (a possible 1.63% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Applied Genetic Techs (AGTC)?

A

The stock price for Applied Genetic Techs (NASDAQ: AGTC) is $0.3936 last updated Today at November 30, 2022, 9:00 PM UTC.

Q

Does Applied Genetic Techs (AGTC) pay a dividend?

A

There are no upcoming dividends for Applied Genetic Techs.

Q

When is Applied Genetic Techs (NASDAQ:AGTC) reporting earnings?

A

Applied Genetic Techs’s Q2 earnings are confirmed for Monday, February 13, 2023.

Q

Is Applied Genetic Techs (AGTC) going to split?

A

There is no upcoming split for Applied Genetic Techs.

Q

What sector and industry does Applied Genetic Techs (AGTC) operate in?

A

Applied Genetic Techs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.